Doctors across America are rapidly adopting OpenEvidence, a free AI-powered chatbot that relies on peer-reviewed literature to answer medical questions. But its CEO, Daniel Nadler, says the model that made OpenEvidence ubiquitous — free for doctors, paid for by ads from pharmaceutical companies and others — may not be the one that the company wants to take into the future.
Just a moment.
We are getting your experience ready.
